Anabolic and anticatabolic agents in critical care

Mile Stanojcic, Celeste C. Finnerty, Marc G. Jeschke

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations


Profound metabolic derangements occur in critically ill patients; this hypermetabolic response is a major contributor to adverse outcomes. Despite the pharmacological therapies currently available to counteract this devastating cascade, future studies are warranted to explore new multimodality agents that will counteract these effects while maintaining glycemic control and preventing unfavorable complications.

Original languageEnglish (US)
Pages (from-to)325-331
Number of pages7
JournalCurrent Opinion in Critical Care
Issue number4
StatePublished - Aug 1 2016


  • anabolic
  • anticatabolic
  • burns
  • critical illness
  • hypermetabolism
  • insulin
  • metformin
  • oxandrolone
  • propranolol

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Anabolic and anticatabolic agents in critical care'. Together they form a unique fingerprint.

Cite this